Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Karl Kieburtz, Daniel J. Lee et al.|The Lancet Neurology|2023Cited by 128
Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalitiesMatthew J. Moulton, Kosuke Izumi, Kristhen N Atala et al.|Genetics in Medicine|2024Cited by 4
Biallelic LAMP3 variants in 5 families with interstitial lung disease: Evidence of a disease-gene associationLaura Keehan, Michael F. Wangler, Hitomi Ono Minagi et al.|Genetics in Medicine|2026Cited by 3